| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 49, 462-466, Copyright © 1979 by Endocrine Society
ARTICLES |
H Heath 3d, PW Lambert, FJ Service and SB Arnaud
Experimentally diabetic rats have low serum 1,25-dihydroxyvitamin D, intestinal malabsorption of calcium, secondary hyperparathyroidism, and bone loss. To examine the hypothesis that abnormalities similar to those in the diabetic rat might explain human diabetic osteopenia, we studied calcium metabolism in 40 healthy control and 82 diabetic patients aged 18--75 yr [47 untreated: fasting plasma glucose (mean +/- SE), 267 +/- 8 mg/dl; 19 treated but hyperglycemic: glucose 305 +/- 24 mg/dl; 16 treated and in better control: glucose, 146 +/- 8 mg/dl]. Serum total calcium, ionic calcium, immunoreactive parathyroid hormone (Arnaud method, GP-1M and CH-12M antisera), 25-hydroxyvitamin D (Haddad method), and 1,25-dihydroxyvitamin D (Lambert method) concentrations were normal in all 3 groups of diabetics and were not significantly different from values in the control group. We determined absorption of calcium from the intestine by a double isotope method (100 mg Ca carrier; normal range, 40--80%) in 11 control and 13 untreated, uncontrolled diabetics (mean plasma glucose, 285 +/- 17 mg/dl). Absorption of calcium in controls was 60 +/- 3% and in diabetics was 56 +/- 3% (not significantly different). We have found no derangement of calcium metabolism in adults with insulin-requiring juvenile- and adult- onset diabetes regardless of treatment status. The experimental diabetic rat model does not appear to be useful for determining the pathogenesis of adult human diabetic osteopenia.
This article has been cited by other articles:
 |
|
 |
|
  A. G. Pittas, J. Lau, F. B. Hu, and B. Dawson-Hughes The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2017 - 2029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Dobnig, J. C. Piswanger-Solkner, M. Roth, B. Obermayer-Pietsch, A. Tiran, A. Strele, E. Maier, P. Maritschnegg, C. Sieberer, and A. Fahrleitner-Pammer Type 2 Diabetes Mellitus in Nursing Home Patients: Effects on Bone Turnover, Bone Mass, and Fracture Risk J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3355 - 3363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Galluzzi, S. Stagi, R. Salti, S. Toni, E. Piscitelli, G. Simonini, F. Falcini, and F. Chiarelli Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status Eur. J. Endocrinol., December 1, 2005; 153(6): 879 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Santana, L. Xu, H. B. Chase, S. Amar, D. T. Graves, and P. C. Trackman A Role for Advanced Glycation End Products in Diminished Bone Healing in Type 1 Diabetes Diabetes, June 1, 2003; 52(6): 1502 - 1510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.M. V. Narayan, R. L. Hanson, C. J. Smith, R. G. Nelson, S. B. Gyenizse, D. J. Pettitt, and W. C. Knowler Dietary Calcium and Blood Pressure in a Native American Population J. Am. Coll. Nutr., February 1, 1998; 17(1): 59 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Heath III Bone Mineral Density in Non-Insulin-Dependent Diabetes Ann Intern Med, August 1, 1996; 125(3): 253 - 253. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
